Onglyza (containing saxagliptin) is a medication marketed to type 2 diabetes sufferers to manage their symptoms. Onglyza has been linked to an increased risk for heart failure (particularly among individuals with type 2 diabetes who also suffer from heart or kidney...
Onglyza (Saxagliptin) Linked to Life-Threatening Heart Problems
read more